Abstract
Many children with a late steroid-resistant nephrotic syndrome (SRNS) and focal glomerulosclerosis have a poor prognosis and enter end-stage renal failure (ESRF) within five years. Reports are scarce on the long-term follow-up of patients entering remission while receiving immunosuppressive therapy after steroids have failed. A two-year-old boy with focal and segmental glomerulosclerosis having both late steroid and cyclophosphamide resistance entered complete remission of the SRNS almost two years after starting induction therapy with cyclosporine A (CSA). During the 15-year follow-up, the patient experienced five relapses during CSA maintenance therapy. All relapses were successfully treated within 10 days by intravenous methylprednisolone pulses in addition to CSA. The relapses were accompanied by a drop in the glomerular filtration rate (GFR). At the age of 18 years, the patient had grade II chronic kidney disease (GFR=61 ml/min/1.73 m2). At the age of 14 years, mycophenolate mofetil (MMF) was added to the maintenance therapy and the CSA dosage was reduced. Two renal biopsies at the ages of 10 and 18 years failed to detect CSA nephrotoxicity. We conclude that children with SRNS may have long-term benefit from a combination therapy using intravenous methylprednisolone pulses and CSA.
References
Loirat C, Ehrich JHH, Geerlings W, Jones EHP, Landais P, Mallick NP, Margreiter R, Raine AEG, Salmela K, Selwood NH, Tufveson G, Valderrabano F (1994) Report on management of renal failure in children in Europe, XXIII, 1992. Nephrol Dial Transplant 9(Suppl 1):26–40
U.S. Renal Data System, USRDS (1999) Annual data report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, p 117
Vehaskari VM (1999) Treatment practices of FSGS among North American pediatric nephrologists. Pediatr Nephrol 13(4):301–303
Habashy D, Hodson EM, Craig JC (2003) Interventions for steroid-resistant nephrotic syndrome: a systematic review. Pediatr Nephrol 18(9):906–921
Kim JS, Bellew CA, Silverstein DM, Aviles DH, Boineau FG, Vehaskari VM (2005) High incidence of initial and late steroid resistance in childhood nephrotic syndrome. Kidney Int 68(3):1275–1281
Ghiggeri GM, Catarsi P, Scolari F, Caridi G, Bertelli R, Carrea A, Sanna-Cherchi S, Emma F, Allegri L, Cancarini G, Rizzoni GF, Perfumo F (2004) Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study. Clin Ther 26(9):1411–1418
Abrantes MM, Cardoso LS, Lima EM, Penido Silva JM, Diniz JS, Bambirra EA, Oliveira EA (2006) Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis. Pediatr Nephrol 21(7):1003–1012
Gipson DS, Chin H, Presler TP, Jennette C, Ferris ME, Massengill S, Gibson K, Thomas DB (2006) Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol 21(3):344–349
Benchimol C (2003) Focal segmental glomerulosclerosis: pathogenesis and treatment. Curr Opin Pediatr 15(2):171–180
Meyrier A (2004) Nephrotic focal segmental glomerulosclerosis in 2004: an update. Nephrol Dial Transplant 19(10):2437–2444
Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE; Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106(14):1777–1782
Moudgil A, Bagga A, Jordan SC (2005) Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions. Pediatr Nephrol 20(10):1376–1381
Yorgin PD, Krasher J, Al-Urzi AY (2001) Pulse methylprednisolone treatment of idiopathic steroid-resistant nephrotic syndrome. Pediatr Nephrol 16(3):245–250
Ehrich JHH, Geerlings C, Zivicnjak M, Franke D, Gellermann J (2006) Steroid-resistant nephrotic syndrome with FSGS: improved remission rate after combination therapy. Nephrol Dial Transplant 21(Suppl 4):330
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Drube, J., Geerlings, C., Taylor, R. et al. Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A. Pediatr Nephrol 22, 600–602 (2007). https://doi.org/10.1007/s00467-006-0398-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0398-6